건강 진단 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Health Check-Up Market was valued at USD 57.4 billion in 2024 and is projected to expand at a CAGR of 6.6% from 2025 to 2034, driven by the increasing prevalence of chronic illnesses such as cancer, diabetes, and cardiovascular disorders. As more individuals prioritize preventive care, the demand for routine medical screenings continues to rise, ensuring early detection and improved treatment outcomes. With advancements in diagnostic technologies making screenings more accessible, healthcare providers and insurers are emphasizing the importance of early diagnosis, further propelling market expansion.

As the awareness of proactive health management gains traction, routine check-ups are becoming an integral part of healthcare strategies worldwide. Insurers are increasingly incorporating preventive screenings into coverage plans, encouraging individuals to undergo regular medical evaluations. Governments and private healthcare providers are also launching awareness campaigns and health programs to promote preventive screenings. The convenience of home-based diagnostic services, the growing penetration of telehealth, and the development of AI-driven diagnostic tools are transforming the health check-up landscape, making screenings more efficient and widely available. Additionally, increased employer initiatives supporting employee health and wellness programs are boosting participation in regular health assessments.

The market is segmented by type into general health check-ups, specialized health check-ups, preventive health check-ups, and routine and wellness health check-ups. Among these, the general health check-up segment remains a dominant force in market growth. This segment is expected to expand at a CAGR of 6.5%, reaching USD 41.3 billion by 2034. Routine medical screenings enable early disease detection, reducing the risk of severe health complications and facilitating timely medical interventions. Many health insurance plans now include regular check-ups, ensuring individuals receive essential evaluations to maintain their overall well-being.

Based on test type, the health check-up market comprises complete blood count tests, blood glucose tests, kidney function tests, bone profile tests, electrolyte tests, liver function tests, lipid profile tests, cardiac biomarkers, hormone and vitamin assessments, tumor markers, and other diagnostics. The complete blood count test segment is a key contributor to market expansion, projected to grow at a CAGR of 6.2% and reach USD 24.1 billion by 2034. These tests offer vital insights into blood cell composition, including red and white blood cell counts and platelet levels, enabling healthcare providers to diagnose conditions such as anemia, infections, and blood disorders. Hemoglobin and hematocrit measurements also help assess nutritional status, aiding in the identification of iron deficiency and other health concerns.

The US health check-up market, valued at USD 19.1 billion in 2024, is expected to grow at a CAGR of 5.7% between 2025 and 2034. The rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions is driving the need for frequent screenings. Additionally, the aging population requires consistent and comprehensive medical assessments, further fueling the demand for preventive healthcare services. With healthcare providers and insurers actively promoting early intervention, routine medical evaluations in the US are becoming increasingly common. As awareness surrounding proactive health management continues to grow, the health check-up market is poised for sustained expansion over the next decade.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Surging investments in population screening
    • 3.2.1.2 Increasing prevalence of diseases
    • 3.2.1.3 Rise in geriatric population
    • 3.2.1.4 Increasing adoption of digital technology
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with screening
    • 3.2.2.2 Lack of awareness and proper infrastructure in under-developed regions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends
• 3.11 Value chain analysis
• 3.12 Health check-up packages outline
• 3.13 Start-up scenario

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 General health check-up
• 5.3 Routine and wellness health check-up
• 5.4 Specialized health check-up
• 5.5 Preventive health check-up

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Complete blood count test
• 6.3 Blood glucose test
• 6.4 Electrolyte test
• 6.5 Lipid profile test
• 6.6 Hormones & vitamins
• 6.7 Tumor markers
• 6.8 Liver function test
• 6.9 Cardiac biomarkers
• 6.10 Kidney function test
• 6.11 Bone profile test
• 6.12 Other test types

Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Blood
• 7.3 Urine
• 7.4 Saliva
• 7.5 Other sample types

Chapter 8 Market Estimates and Forecast, By Panel Type, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Multi-test panels
• 8.3 Single-test panels

Chapter 9 Market Estimates and Forecast, By Service Provider, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospital-based laboratories
• 9.3 Standalone laboratories
• 9.4 Ambulatory care centers
• 9.5 Central laboratories
• 9.6 Other service providers

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 ARUP Laboratories
• 11.2 Cerba Healthcare
• 11.3 eurofins
• 11.4 Exact Sciences
• 11.5 GRAIL
• 11.6 INNOVA
• 11.7 labcorp
• 11.8 natera
• 11.9 OPKO
• 11.10 Q2 Solutions
• 11.11 Quest Diagnostics
• 11.12 Sonic Healthcare
• 11.13 SYNLAB
• 11.14 Trinity Biotech
• 11.15 UNILABS